Page last updated: 2024-11-02

oxybutynin and Acquired Immune Deficiency Syndrome

oxybutynin has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
"Both buprenorphine and fentanyl were well tolerated."1.39Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients. ( Cannata, F; Canneti, A; Di Marco, P; Luzi, M; Pasqualitto, F; Reale, C; Spinoglio, A, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canneti, A1
Luzi, M1
Di Marco, P1
Cannata, F1
Pasqualitto, F1
Spinoglio, A1
Reale, C1

Other Studies

1 other study available for oxybutynin and Acquired Immune Deficiency Syndrome

ArticleYear
Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.
    Minerva anestesiologica, 2013, Volume: 79, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Analgesics, Opioid; Buprenorphine; CD4-CD8 Ratio; Female;

2013